BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 15314690)

  • 1. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
    J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
    Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
    J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.
    Zheng L; Settle M; Brubaker G; Schmitt D; Hazen SL; Smith JD; Kinter M
    J Biol Chem; 2005 Jan; 280(1):38-47. PubMed ID: 15498770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
    Lu N; Xie S; Li J; Tian R; Peng YY
    Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
    Shao B
    Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
    Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
    J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease.
    Shao B; Oda MN; Vaisar T; Oram JF; Heinecke JW
    Curr Opin Mol Ther; 2006 Jun; 8(3):198-205. PubMed ID: 16774039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
    Jin Z; Zhou L; Tian R; Lu N
    Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
    Nicholls SJ; Zheng L; Hazen SL
    Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.
    Shao B; Pennathur S; Heinecke JW
    J Biol Chem; 2012 Feb; 287(9):6375-86. PubMed ID: 22219194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export.
    Shao B; Tang C; Heinecke JW; Oram JF
    J Lipid Res; 2010 Jul; 51(7):1849-58. PubMed ID: 20064972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
    Vivekanandan-Giri A; Slocum JL; Byun J; Tang C; Sands RL; Gillespie BW; Heinecke JW; Saran R; Kaplan MJ; Pennathur S
    Ann Rheum Dis; 2013 Oct; 72(10):1725-31. PubMed ID: 23313808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway.
    Shao B; Heinecke JW
    J Proteomics; 2011 Oct; 74(11):2289-99. PubMed ID: 21501700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.
    Bergt C; Pennathur S; Fu X; Byun J; O'Brien K; McDonald TO; Singh P; Anantharamaiah GM; Chait A; Brunzell J; Geary RL; Oram JF; Heinecke JW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13032-7. PubMed ID: 15326314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using adenovirus-mediated gene transfer to study the effect of myeloperoxidase on plasma lipid levels, HDL structure and functionality in mice expressing human apoA-I forms.
    Dalakoura-Karagkouni K; Tiniakou I; Zannis VI; Kardassis D
    Biochem Biophys Res Commun; 2022 Sep; 622():108-114. PubMed ID: 35843089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
    Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
    J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I.
    Hossain MA; Ngeth S; Chan T; Oda MN; Francis GA
    BMC Biochem; 2012 Jan; 13():1. PubMed ID: 22248050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
    Shao B; Oda MN; Oram JF; Heinecke JW
    Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.